ATC code
Appearance
List of ATC groups
A Alimentary tract and metabolism
- A01 Stomatological preparations
- A01A Stomatological preparations
- A01AA Caries prophylactic agents
- A01AB Anti-infectives and antiseptics for local oral treatment
- A01AC Corticosteroids for local oral treatment
- A01AD Other agents for local oral treatment
- A01A Stomatological preparations
- A02 Drugs for acid related disorders
- A02A Antacids
- A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
- A02BA H2-receptor antagonists
- A02BB Prostaglandins
- A02BC Proton pump inhibitors
- A02BD Combinations for eradication of Helicobacter pylori
- A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
- A02X Other drugs for acid related disorders
- A03 Drugs for functional gastrointestinal disorders
- A03A Drugs for functional bowel disorders
- A03AA Synthetic anticholinergics, esters with tertiary amino group
- A03AB Synthetic anticholinergics, quaternary ammonium compounds
- A03AC Synthetic antispasmodics, amides with tertiary amines
- A03AD Papaverine and derivatives
- A03AE Drugs acting on serotonin receptors
- A03AX Other drugs for functional bowel disorders
- A03B Belladonna and derivatives, plain
- A03BA Belladonna alkaloids, tertiary amines
- A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
- A03C Antispasmodics in combination with psycholeptics
- A03CA Synthetic anticholinergic agents in combination with psycholeptics
- A03CB Belladonna and derivatives in combination with psycholeptics
- A03CC Other antispasmodics in combination with psycholeptics
- A03D Antispasmodics in combination with analgesics
- A03DA Synthetic anticholinergic agents in combination with analgesics
- A03DB Belladonna and derivatives in combination with analgesics
- A03DC Other antispasmodics in combination with analgesics
- A03E Antispasmodics and anticholinergics in combination with other drugs
- A03EA Antispasmodics, psycholeptics and analgesics in combination
- A03ED Antispasmodics in combination with other drugs
- A03F Propulsives
- A03FA Propulsives
- A03A Drugs for functional bowel disorders
- A04 Antiemetics and antinauseants
- A04A Antiemetics and antinauseants
- A04AA Serotonin (5HT3) antagonists
- A04AD Other antiemetics
- A04A Antiemetics and antinauseants
- A05 Bile and liver therapy
- A05A Bile therapy
- A05AA Bile acid preparations
- A05AB Preparations for biliary tract therapy
- A05AX Other drugs for bile therapy
- A05B Liver therapy, lipotropics
- A05BA Liver therapy
- A05C Drugs for bile therapy and lipotropics in combination
- A05A Bile therapy
- A06 Laxatives
- A06A Laxatives
- A06AA Softeners, emollients
- A06AB Contact laxatives
- A06AC Bulk producers
- A06AD Osmotically acting laxatives
- A06AG Enemas
- A06AX Other laxatives
- A06A Laxatives
- A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
- A07A Intestinal anti-infectives
- A07AA Antibiotics
- A07AB Sulfonamides
- A07AC Imidazole derivatives
- A07AX Other intestinal anti-infectives
- A07B Intestinal adsorbents
- A07BA Charcoal preparations
- A07BB Bismuth preparations
- A07BC Other intestinal adsorbents
- A07C Electrolytes with carbohydrates
- A07CA Oral rehydration salt formulations
- A07D Antipropulsives
- A07DA Antipropulsives
- A07E Intestinal anti-inflammatory agents
- A07EA Corticosteroids acting locally
- A07EB Antiallergic agents, excluding corticosteroids
- A07EC Aminosalicylic acid and similar agents
- A07F Antidiarrheal micro-organisms
- A07FA Antidiarrheal micro-organisms
- A07X Other antidiarrheals
- A07XA Other antidiarrheals
- A07A Intestinal anti-infectives
- A08 Antiobesity preparations, excluding diet products
- A08A Antiobesity preparations, excluding diet products
- A08AA Centrally acting antiobesity products
- A08AB Peripherally acting antiobesity products
- A08A Antiobesity preparations, excluding diet products
- A09 Digestives, including enzymes
- A09A Digestives, including enzymes
- A09AA Enzyme preparations
- A09AB Acid preparations
- A09AC Enzyme and acid preparations, combinations
- A09A Digestives, including enzymes
- A10 Drugs used in diabetes
- A10A Insulins and analogues
- A10AB Insulins and analogues, fast-acting
- A10AC Insulins and analogues, intermediate-acting
- A10AD Insulins and analogues, intermediate-acting combined with fast-acting
- A10AE Insulins and analogues, long-acting
- A10B Oral blood glucose lowering drugs
- A10BA Biguanides
- A10BB Sulfonamides, urea derivatives
- A10BC Sulfonamides (heterocyclic)
- A10BD Combinations of oral blood glucose lowering drugs
- A10BF Alpha glucosidase inhibitors
- A10BG Thiazolidinediones
- A10BX Other oral blood glucose lowering drugs
- A10X Other drugs used in diabetes
- A10XA Aldose reductase inhibitors
- A10A Insulins and analogues
- A11 Vitamins
- A11A Multivitamins, combinations
- A11AA Multivitamins with minerals
- A11B Multivitamins, plain
- A11BA Multivitamins, plain
- A11C Vitamin A and D, including combinations of the two
- A11CA Vitamin A, plain
- A11CB Vitamin A and D in combination
- A11CC Vitamin D and analogues
- A11D Vitamin B1, plain and in combination with vitamin B6 and B12
- A11DA Vitamin B1, plain
- A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12
- A11E Vitamin B-complex, including combinations
- A11EA Vitamin B-complex, plain
- A11EB Vitamin B-complex with vitamin C
- A11EC Vitamin B-complex with minerals
- A11ED Vitamin B-complex with anabolic steroids
- A11EX Vitamin B-complex, other combinations
- A11G Ascorbic acid (vitamin C), including combinations
- A11GA Ascorbic acid (vitamin C), plain
- A11GB Ascorbic acid (vitamin C), combinations
- A11H Other plain vitamin preparations
- A11HA Other plain vitamin preparations
- A11J Other vitamin products, combinations
- A11JA Combinations of vitamins
- A11JB Vitamins with minerals
- A11JC Vitamins, other combinations
- A11A Multivitamins, combinations
- A12 Mineral supplements
- A13 Tonics
- A13A tonics
- A14 Anabolic agents for systemic use
- A15 Appetite stimulants
- A16 Other alimentary tract and metabolism products
- A16A Other alimentary tract and metabolism products
- A16AA Amino acids and derivatives
- A16AB Enzymes
- A16AX Various alimentary tract and metabolism products
- A16A Other alimentary tract and metabolism products
B Blood and blood forming organs
- B01 Antithrombotic agents
- B02 Antihemorrhagics
- B02A Antifibrinolytics
- B02AA Amino acids
- B02AB Proteinase inhibitors
- B02B Vitamin K and other hemostatics
- B02BA Vitamin K
- B02BB Fibrinogen
- B02BC Local hemostatics
- B02BD Blood coagulation factors
- B02BX Other systemic hemostatics
- B02A Antifibrinolytics
- B03 Antianemic preparations
- B03A Iron preparations
- B03AA Iron bivalent, oral preparations
- B03AB Iron trivalent, oral preparations
- B03AC Iron trivalent, parenteral preparations
- B03AD Iron in combination with folic acid
- B03AE Iron in other combinations
- B03B Vitamin B12 and folic acid
- B03BA Vitamin B12 (cyanocobalamin and analogues)
- B03BB Folic acid and derivatives
- B03X Other antianemic preparations
- B03XA Other antianemic preparations
- B03A Iron preparations
- B05 Blood substitutes and perfusion solutions
- B05A Blood and related products
- B05AA Blood substitutes and plasma protein fractions
- B05B I.V. Solutions
- B05BA Solutions for parenteral nutrition
- B05BB Solutions affecting the electrolyte balance
- B05BC Solutions producing osmotic diuresis
- B05C Irrigating solutions
- B05CA Anti-infectives
- B05CB Salt solutions
- B05CX Other irrigating solutions
- B05D Peritoneal dialytics
- B05DA Isotonic solutions
- B05DB Hypertonic solutions
- B05X I.V. Solution additives
- B05XA Electrolyte solutions
- B05XB Amino acids
- B05XC Vitamins
- B05XX Other I.V. solution additives
- B05Z Hemodialytics and hemofiltrates
- B05ZA Hemodialytics, concentrates
- B05ZB Hemofiltrates
- B05A Blood and related products
- B06 Other hematological agents
- B06A Other hematological agents
- B06AA Enzymes
- B06AB Other hematological products
- B06A Other hematological agents
C Cardiovascular system
- C01 Cardiac therapy
- C01A Cardiac glycosides
- C01AA Digitalis glycosides
- C01AB Scilla glycosides
- C01AC Strophantus glycosides
- C01AX Other cardiac glycosides
- C01B Antiarrhythmics, class I and III
- C01BA Antiarrhythmics, class Ia
- C01BB Antiarrhythmics, class Ib
- C01BC Antiarrhythmics, class Ic
- C01BD Antiarrhythmics, class III
- C01BG Other class I antiarrhythmics
- C01C Cardiac stimulants excluding cardiac glycosides
- C01CA Adrenergic and dopaminergic agents
- C01CE Phosphodiesterase inhibitors
- C01CX Other cardiac stimulants
- C01D Vasodilators used in cardiac diseases
- C01E Other cardiac preparations
- C01EA Prostaglandins
- C01EB Other cardiac preparations
- C01EX Other cardiac combination products
- C01A Cardiac glycosides
- C02 Antihypertensives
- C02A Antiadrenergic agents, centrally acting
- C02AA Rauwolfia alkaloids
- C02AB Methyldopa
- C02AC Imidazoline receptor agonists
- C02B Antiadrenergic agents, ganglion-blocking
- C02C Antiadrenergic agents, peripherally acting
- C02CA Alpha-adrenoreceptor antagonists
- C02CC Guanidine derivatives
- C02D Arteriolar smooth muscle, agents acting on
- C02DA Thiazide derivatives
- C02DB Hydrazinophthalazine derivatives
- C02DC Pyrimidine derivatives
- C02DD Nitroferricyanide derivatives
- C02DG Guanidine derivatives
- C02K Other antihypertensives
- C02L Antihypertensives and diuretics in combination
- C02LA Rauwolfia alkaloids and diuretics in combination
- C02LB Methyldopa and diuretics in combination
- C02LC Imidazoline receptor agonists in combination with diuretics
- C02LE Alpha-adrenoreceptor antagonists and diuretics
- C02LF Guanidine derivatives and diuretics
- C02LG Hydrazinophthalazine derivatives and diuretics
- C02LK Alkaloids, excluding rauwolfia, in combination with diuretics
- C02LL MAO inhibitors and diuretics
- C02LN Serotonin antagonists and diuretics
- C02LX Other antihypertensives and diuretics
- C02N Combinations of antihypertensives in ATC-group C02
- C02A Antiadrenergic agents, centrally acting
- C03 Diuretics
- C03A Low-ceiling diuretics, thiazides
- C03AA Thiazides, plain
- C03AB Thiazides and potassium in combination
- C03AH Thiazides, combinations with psycholeptics and/or analgesics
- C03AX Thiazides, combinations with other drugs
- C03B Low-ceiling diuretics, excluding thiazides
- C03BA Sulfonamides, plain
- C03BB Sulfonamides and potassium in combination
- C03BC Mercurial diuretics
- C03BD Xanthine derivatives
- C03BK Sulfonamides, combinations with other drugs
- C03BX Other low-ceiling diuretics
- C03C High-ceiling diuretics
- C03CA Sulfonamides, plain
- C03CB Sulfonamides and potassium in combination
- C03CC Aryloxyacetic acid derivatives
- C03CD Pyrazolone derivatives
- C03CX Other high-ceiling diuretics
- C03D Potassium-sparing agents
- C03DA Aldosterone antagonists
- C03DB Other potassium-sparing agents
- C03E Diuretics and potassium-sparing agents in combination
- C03EA Low-ceiling diuretics and potassium-sparing agents
- C03EB High-ceiling diuretics and potassium-sparing agents
- C03A Low-ceiling diuretics, thiazides
- C04 Peripheral vasodilators
- C04A Peripheral vasodilators
- C04AA 2-amino-1-phenylethanol derivatives
- C04AB Imidazoline derivatives
- C04AC Nicotinic acid and derivatives
- C04AD Purine derivatives
- C04AE Ergot alkaloids
- C04AF Enzymes
- C04AX Other peripheral vasodilators
- C04A Peripheral vasodilators
- C05 Vasoprotectives
- C05A Antihemorrhoidals for topical use
- C05AA Products containing corticosteroids
- C05AB Products containing antibiotics
- C05AD Products containing local anesthetics
- C05AX Other antihemorrhoidals for topical use
- C05B Antivaricose therapy
- C05BA Heparins or heparinoids for topical use
- C05BB Sclerosing agents for local injection
- C05BX Other sclerosing agents
- C05C Capillary stabilising agents
- C05CA Bioflavonoids
- C05CX Other capillary stabilising agents
- C05A Antihemorrhoidals for topical use
- C07 Beta blocking agents
- C07A Beta blocking agents
- C07AA Beta blocking agents, non-selective
- C07AB Beta blocking agents, selective
- C07AG Alpha and beta blocking agents
- C07B Beta blocking agents and thiazides
- C07BA Beta blocking agents, non-selective, and thiazides
- C07BB Beta blocking agents, selective, and thiazides
- C07BG Alpha and beta blocking agents and thiazides
- C07C Beta blocking agents and other diuretics
- C07CA Beta blocking agents, non-selective, and other diuretics
- C07CB Beta blocking agents, selective, and other diuretics
- C07CG Alpha and beta blocking agents and other diuretics
- C07D Beta blocking agents, thiazides and other diuretics
- C07DA Beta blocking agents, non-selective, thiazides and other diuretics
- C07DB Beta blocking agents, selective, thiazides and other diuretics
- C07E Beta blocking agents and vasodilators
- C07EA Beta blocking agents, non-selective, and vasodilators
- C07EB Beta blocking agents, selective, and vasodilators
- C07F Beta blocking agents and other antihypertensives
- C07FA Beta blocking agents, non-selective, and other antihypertensives
- C07FB Beta blocking agents, selective, and other antihypertensives
- C07A Beta blocking agents
- C08 Calcium channel blockers
- C08C Selective calcium channel blockers with mainly vascular effects
- C08CA Dihydropyridine derivatives
- C08CX Other selective calcium channel blockers with mainly vascular effects
- C08D Selective calcium channel blockers with direct cardiac effects
- C08DA Phenylalkylamine derivatives
- C08DB Benzothiazepine derivatives
- C08E Non-selective calcium channel blockers
- C08EA Phenylalkylamine derivatives
- C08EX Other non-selective calcium channel blockers
- C08G Calcium channel blockers and diuretics
- C08GA Calcium channel blockers and diuretics
- C08C Selective calcium channel blockers with mainly vascular effects
- C09 Agents acting on the renin-angiotensin system
- C09A ACE inhibitors, plain
- C09AA ACE inhibitors, plain
- C09B ACE inhibitors, combinations
- C09BA ACE inhibitors and diuretics
- C09BB ACE inhibitors and calcium channel blockers
- C09C Angiotensin II antagonists, plain
- C09CA Angiotensin II antagonists, plain
- C09D Angiotensin II antagonists, combinations
- C09DA Angiotensin II antagonists and diuretics
- C09X Other agents acting on the renin-angiotensin system
- C09XA Renin-inhibitors
- C09A ACE inhibitors, plain
- C10 Serum lipid reducing agents
- C10A Cholesterol and triglyceride reducers
- C10AA HMG CoA reductase inhibitors
- C10AB Fibrates
- C10AC Bile acid sequestrants
- C10AD Nicotinic acid and derivatives
- C10AX Other cholesterol and triglyceride reducers
- C10A Cholesterol and triglyceride reducers
D Dermatologicals
- D01 Antifungals for dermatological use
- D01A Antifungals for topical use
- D01AA Antibiotics
- D01AC Imidazole and triazole derivatives
- D01AE Other antifungals for topical use
- D01B Antifungals for systemic use
- D01BA Antifungals for systemic use
- D01A Antifungals for topical use
- D02 Emollients and protectives
- D02A Emollients and protectives
- D02AA Silicone products
- D02AB Zinc products
- D02AC Soft paraffin and fat products
- D02AD Liquid plasters
- D02AE Carbamide products
- D02AF Salicylic acid preparations
- D02AX Other emollients and protectives
- D02B Protectives against UV-radiation
- D02BA Protectives against UV-radiation for topical use
- D02BB Protectives against UV-radiation for systemic use
- D02A Emollients and protectives
- D03 Preparations for treatment of wounds and ulcers
- D03A Cicatrizants
- D03AA Cod-liver oil ointments
- D03AX Other cicatrizants
- D03B Enzymes
- D03BA Proteolytic enzymes
- D03A Cicatrizants
- D04 Antipruritics, including antihistamines, anesthetics, etc.
- D04A Antipruritics, including antihistamines, anesthetics, etc.
- D04AA Antihistamines for topical use
- D04AB Anesthetics for topical use
- D04AX Other antipruritics
- D04A Antipruritics, including antihistamines, anesthetics, etc.
- D05 Antipsoriatics
- D05A Antipsoriatics for topical use
- D05B Antipsoriatics for systemic use
- D06 Antibiotics and chemotherapeutics for dermatological use
- D06A Antibiotics for topical use
- D06AA Tetracycline and derivatives
- D06AX Other antibiotics for topical use
- D06B Chemotherapeutics for topical use
- D06BA Sulfonamides
- D06BB Antivirals
- D06BX Other chemotherapeutics
- D06C Antibiotics and chemotherapeutics, combinations
- D06A Antibiotics for topical use
- D07 Corticosteroids, dermatological preparations
- D07A Corticosteroids, plain
- D07AA Corticosteroids, weak (group I)
- D07AB Corticosteroids, moderately potent (group II)
- D07AC Corticosteroids, potent (group III)
- D07AD Corticosteroids, very potent (group IV)
- D07B Corticosteroids, combinations with antiseptics
- D07BA Corticosteroids, weak, combinations with antiseptics
- D07BB Corticosteroids, moderately potent, combinations with antiseptics
- D07BC Corticosteroids, potent, combinations with antiseptics
- D07BD Corticosteroids, very potent, combinations with antiseptics
- D07C Corticosteroids, combinations with antibiotics
- D07CA Corticosteroids, weak, combinations with antibiotics
- D07CB Corticosteroids, moderately potent, combinations with antibiotics
- D07CC Corticosteroids, potent, combinations with antibiotics
- D07CD Corticosteroids, very potent, combinations with antibiotics
- D07X Corticosteroids, other combinations
- D07XA Corticosteroids, weak, other combinations
- D07XB Corticosteroids, moderately potent, other combinations
- D07XC Corticosteroids, potent, other combinations
- D07XD Corticosteroids, very potent, other combinations
- D07A Corticosteroids, plain
- D08 Antiseptics and disinfectants
- D08A Antiseptics and disinfectants
- D08AA Acridine derivatives
- D08AB Aluminium agents
- D08AC Biguanides and amidines
- D08AD Boric acid products
- D08AE Phenol and derivatives
- D08AF Nitrofuran derivatives
- D08AG Iodine products
- D08AH Quinoline derivatives
- D08AJ Quaternary ammonium compounds
- D08AK Mercurial products
- D08AL Silver compounds
- D08AX Other antiseptics and disinfectants
- D08A Antiseptics and disinfectants
- D09 Medicated dressings
- D09A Medicated dressings
- D09AA Ointment dressings with anti-infectives
- D09AB Zinc bandages
- D09AX Soft paraffin dressings
- D09A Medicated dressings
- D10 Anti-acne preparations
- D10A Anti-acne preparations for topical use
- D10B Anti-acne preparations for systemic use
- D10BA Retinoids for treatment of acne
- D10BX Other anti-acne preparations for systemic use
- D11 Other dermatological preparations
- D11A Other dermatological preparations
- D11AA Antihidrotics
- D11AC Medicated shampoos
- D11AE Androgens for topical use
- D11AF Wart and anti- corn preparations
- D11AX Other dermatologicals
- D11A Other dermatological preparations
G Genito-urinary system and sex hormones
- G01 Gynecological anti-infectives and antiseptics
- G01A Anti-infectives and antiseptics, excluding combinations with corticosteroids
- G01AA Antibiotics
- G01AB Arsenic compounds
- G01AC Quinoline derivatives
- G01AD Organic acids
- G01AE Sulfonamides
- G01AF Imidazole derivatives
- G01AG Triazole derivatives
- G01AX Other anti-infectives and antiseptics
- G01B Anti-infectives/antiseptics in combination with corticosteroids
- G01BA Antibiotics and corticosteroids
- G01BC Quinoline derivatives and corticosteroids
- G01BD Antiseptics and corticosteroids
- G01BE Sulfonamides and corticosteroids
- G01BF Imidazole derivatives and corticosteroids
- G01A Anti-infectives and antiseptics, excluding combinations with corticosteroids
- G02 Other gynecologicals
- G02A Oxytocics
- G02AB Ergot alkaloids
- G02AC Ergot alkaloids and oxytocin including analogues, in combination
- G02AD Prostaglandins
- G02AX Other oxytocics
- G02B Contraceptives for topical use
- G02BA Intrauterine contraceptives
- G02BB Intravaginal contraceptives
- G02C Other gynecologicals
- G02CA Sympathomimetics, labour repressants
- G02CB Prolactin inhibitors
- G02CC Anti-inflammatory products for vaginal administration
- G02CX Other gynecologicals
- G02A Oxytocics
- G03 Sex hormones and modulators of the genital system
- G03A Hormonal contraceptives for systemic use
- G03AA Progestogens and estrogens, fixed combinations
- G03AB Progestogens and estrogens, sequential preparations
- G03AC Progestogens
- G03B Androgens
- G03BA 3-oxoandrosten-(4) derivatives
- G03BB 5-androstanon-(3) derivatives
- G03C Estrogens
- G03CA Natural and semisynthetic estrogens, plain
- G03CB Synthetic estrogens, plain
- G03CC Estrogens, combinations with other drugs
- G03D Progestogens
- G03DA Pregnen-(4) derivatives
- G03DB Pregnadien derivatives
- G03DC Estren derivatives
- G03E Androgens and female sex hormones in combination
- G03EA Androgens and estrogens
- G03EB Androgen, progestogen and estrogen in combination
- G03EK Androgens and female sex hormones in combination with other drugs
- G03F Progestogens and estrogens in combination
- G03FA Progestogens and estrogens, fixed combinations
- G03FB Progestogens and estrogens, sequential preparations
- G03G Gonadotropins and other ovulation stimulants
- G03GA Gonadotropins
- G03GB Ovulation stimulants, synthetic
- G03H Antiandrogens
- G03HA Antiandrogens, plain
- G03HB Antiandrogens and estrogens
- G03X Other sex hormones and modulators of the genital system
- G03XA Antigonadotropins and similar agents
- G03XB Antiprogestogens
- G03XC Selective estrogen receptor modulators
- G03A Hormonal contraceptives for systemic use
- G04 Urologicals
- G04B Other urologicals, including antispasmodics
- G04BA Acidifiers
- G04BC Urinary concrement solvents
- G04BD Urinary antispasmodics
- G04BE Drugs used in erectile dysfunction
- G04BX Other urologicals
- G04C Drugs used in benign prostatic hypertrophy
- G04CA Alpha-adrenoreceptor antagonists
- G04CB Testosterone-5-alpha reductase inhibitors
- G04CX Other drugs used in benign prostatic hypertrophy
- G04B Other urologicals, including antispasmodics
H Systemic hormonal preparations, excluding sex hormones and insulins
- H01 Pituitary and hypothalamic hormones and analogues
- H01A Anterior pituitary lobe hormones and analogues
- H01AA Adrenocorticotropic hormone
- H01AB Thyrotropin
- H01AC Somatropin and somatropin agonists
- H01AX Other anterior pituitary lobe hormones and analogues
- H01B Posterior pituitary lobe hormones
- H01BA Vasopressin and analogues
- H01BB Oxytocin and analogues
- H01C Hypothalamic hormones
- H01CA Gonadotropin-releasing hormones
- H01CB Antigrowth hormone
- H01CC Anti-gonadotropin-releasing hormones
- H01A Anterior pituitary lobe hormones and analogues
- H02 Corticosteroids for systemic use
- H02A Corticosteroids for systemic use, plain
- H02AA Mineralocorticoids
- H02AB Glucocorticoids
- H02B Corticosteroids for systemic use, combinations
- H02BX Corticosteroids for systemic use, combinations
- H02C Antiadrenal preparations
- H02CA Anticorticosteroids
- H02A Corticosteroids for systemic use, plain
- H03 Thyroid therapy
- H03A Thyroid preparations
- H03AA Thyroid hormones
- H03B Antithyroid preparations
- H03BA Thiouracils
- H03BB Sulphur-containing imidazole derivatives
- H03BC Perchlorates
- H03BX Other antithyroid preparations
- H03C Iodine therapy
- H03CA Iodine therapy
- H03A Thyroid preparations
- H04 Pancreatic hormones
- H04A Glycogenolytic hormones
- H04AA Glycogenolytic hormones
- H04A Glycogenolytic hormones
- H05 Calcium homeostasis
- H05A Parathyroid hormones and analogues
- H05AA Parathyroid hormones and analogues
- H05B Anti-parathyroid hormones
- H05BA Calcitonin preparations
- H05A Parathyroid hormones and analogues
J Anti-infectives for systemic use
- J01 Antibacterials for systemic use
- J01A Tetracyclines
- J01AA Tetracyclines
- J01B Amphenicols
- J01BA Amphenicols
- J01C Beta-lactam antibacterials, penicillins
- J01CA Penicillins with extended spectrum
- J01CE Beta-lactamase sensitive penicillins
- J01CF Beta-lactamase resistant penicillins
- J01CG Beta-lactamase inhibitors
- J01CR Combinations of penicillins, including beta-lactamase inhibitors
- J01D Other beta-lactam antibacterials
- J01DA Cephalosporins and related substances
- J01DF Monobactams
- J01DH Carbapenems
- J01E Sulfonamides and trimethoprim
- J01EA Trimethoprim and derivatives
- J01EB Short-acting sulfonamides
- J01EC Intermediate-acting sulfonamides
- J01ED Long-acting sulfonamides
- J01EE Combinations of sulfonamides and trimethoprim, including derivatives
- J01F Macrolides, lincosamides and streptogramins
- J01FA Macrolides
- J01FF Lincosamides
- J01FG Streptogramins
- J01G Aminoglycoside antibacterials
- J01GA Streptomycins
- J01GB Other aminoglycosides
- J01M Quinolone antibacterials
- J01MA Fluoroquinolones
- J01MB Other quinolones
- J01R Combinations of antibacterials
- J01RA Combinations of antibacterials
- J01X Other antibacterials
- J01XA Glycopeptide antibacterials
- J01XB Polymyxins
- J01XC Steroid antibacterials
- J01XD Imidazole derivatives
- J01XE Nitrofuran derivatives
- J01XX Other antibacterials
- J01A Tetracyclines
- J02 Antimycotics for systemic use
- J02A Antimycotics for systemic use
- J02AA Antibiotics
- J02AB Imidazole derivatives
- J02AC Triazole derivatives
- J02AX Other antimycotics for systemic use
- J02A Antimycotics for systemic use
- J04 Antimycobacterials
- J04A Drugs for treatment of tuberculosis
- J04AA Aminosalicylic acid and derivatives
- J04AB Antibiotics
- J04AC Hydrazides
- J04AD Thiocarbamide derivatives
- J04AK Other drugs for treatment of tuberculosis
- J04AM Combinations of drugs for treatment of tuberculosis
- J04B Drugs for treatment of leprosy
- J04BA Drugs for treatment of leprosy
- J04A Drugs for treatment of tuberculosis
- J05 Antivirals for systemic use
- J05A Direct acting antivirals
- J05AA Thiosemicarbazones
- J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors
- J05AC Cyclic amines
- J05AD Phosphonic acid derivatives
- J05AE Protease inhibitors
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
- J05AG Non-nucleoside reverse transcriptase inhibitors
- J05AH Neuraminidase inhibitors
- J05AX Other antivirals
- J05A Direct acting antivirals
- J06 Immune sera and immunoglobulins
- J06A Immune sera
- J06AA Immune sera
- J06B Immunoglobulins
- J06BA Immunoglobulins, normal human
- J06BB Specific immunoglobulins
- J06BC Other immunoglobulins
- J06A Immune sera
- J07 Vaccines
- J07A Bacterial vaccines
- J07AC Anthrax vaccines
- J07AD Brucellosis vaccines
- J07AE Cholera vaccines
- J07AF Diphtheria vaccines
- J07AG Haemophilus influenzae B vaccines
- J07AH Meningococcal vaccines
- J07AJ Pertussis vaccines
- J07AK Plague vaccines
- J07AL Pneumococcal vaccines
- J07AM Tetanus vaccines
- J07AN Tuberculosis vaccines
- J07AP Typhoid vaccines
- J07AR Typhus (exanthematicus) vaccines
- J07AX Other bacterial vaccines
- J07B Viral vaccines
- J07BA Encephalitis vaccines
- J07BB Influenza vaccines
- J07BC Hepatitis vaccines
- J07BD Morbilli vaccines
- J07BE Parotitis vaccines
- J07BF Poliomyelitis vaccines
- J07BG Rabies vaccines
- J07BH Rota virus diarrhea vaccines
- J07BJ Rubella vaccines
- J07BK Varicella vaccines
- J07BL Yellow fever vaccines
- J07BX Other viral vaccines
- J07C Bacterial and viral vaccines, combined
- J07CA Bacterial and viral vaccines, combined
- J07X Other vaccines
- J07A Bacterial vaccines
L Antineoplastic and immunomodulating agents
- L01 Antineoplastic agents
- L01A Alkylating agents
- L01AA Nitrogen mustard analogues
- L01AB Alkyl sulfonates
- L01AC Ethylene imines
- L01AD Nitrosoureas
- L01AG Epoxides
- L01AX Other alkylating agents
- L01B Antimetabolites
- L01BA Folic acid analogues
- L01BB Purine analogues
- L01BC Pyrimidine analogues
- L01C Plant alkaloids and other natural products
- L01CA Vinca alkaloids and analogues
- L01CB Podophyllotoxin derivatives
- L01CC Colchicine derivatives
- L01CD Taxanes
- L01CX Other plant alkaloids and natural products
- L01D Cytotoxic antibiotics and related substances
- L01DA Actinomycines
- L01DB Anthracyclines and related substances
- L01DC Other cytotoxic antibiotics
- L01X Other antineoplastic agents
- L01XA Platinum compounds
- L01XB Methylhydrazines
- L01XC Monoclonal antibodies
- L01XD Agents used in photodynamic therapy
- L01XX Other antineoplastic agents
- L01XY Combinations of antineoplastic agents
- L01A Alkylating agents
- L02 Endocrine therapy
- L02A Hormones and related agents
- L02AA Estrogens
- L02AB Progestogens
- L02AE Gonadotropin-releasing hormone analogues
- L02AX Other hormones
- L02B Hormone antagonists and related agents
- L02BA Anti-estrogens
- L02BB Anti-androgens
- L02BG Enzyme inhibitors
- L02A Hormones and related agents
- L03 Immunostimulants
- L03A Cytokines and immunomodulators
- L03AA Colony stimulating factors
- L03AB Interferons
- L03AC Interleukins
- L03AX Other cytokines and immunomodulators
- L03A Cytokines and immunomodulators
- L04 Immunosuppressive agents
- L04A Immunosuppressive agents
- L04AA Selective immunosuppressive agents
- L04AX Other immunosuppressive agents
- L04A Immunosuppressive agents
M Musculo-skeletal system
- M01 Anti-inflammatory and antirheumatic products
- M01A Anti-inflammatory and antirheumatic products, non-steroids
- M01AA Butylpyrazolidines
- M01AB Acetic acid derivatives and related substances
- M01AC Oxicams
- M01AE Propionic acid derivatives
- M01AG Fenamates
- M01AH Coxibs
- M01AX Other anti-inflammatory and antirheumatic agents, non-steroids
- M01B Anti-inflammatory/antirheumatic agents in combination
- M01BA Anti-inflammatory/antirheumatic agents in combination with corticosteroids
- M01BX Other anti-inflammatory/antirheumatic agents in combination with other drugs
- M01C Specific antirheumatic agents
- M01CA Quinolines
- M01CB Gold preparations
- M01CC Penicillamine and similar agents
- M01CX Other specific antirheumatic agents
- M01A Anti-inflammatory and antirheumatic products, non-steroids
- M02 Topical products for joint and muscular pain
- M02A Topical products for joint and muscular pain
- M02AA Anti-inflammatory preparations, non-steroids for topical use
- M02AB Capsicum preparations and similar agents
- M02AC Preparations with salicylic acid derivatives
- M02AX Other topical products for joint and muscular pain
- M02A Topical products for joint and muscular pain
- M03 Muscle relaxants
- M03A Muscle relaxants, peripherally acting agents
- M03B Muscle relaxants, centrally acting agents
- M03BA Carbamic acid esters
- M03BB Oxazol, thiazine, and triazine derivatives
- M03BC Ethers, chemically close to antihistamines
- M03BX Other centrally acting agents
- M03C Muscle relaxants, directly acting agents
- M03CA Dantrolene and derivatives
- M04 Antigout preparations
- M04A Antigout preparations
- M04AA Preparations inhibiting uric acid production
- M04AB Preparations increasing uric acid excretion
- M04AC Preparations with no effect on uric acid metabolism
- M04AX Other antigout preparations
- M04A Antigout preparations
- M05 Drugs for treatment of bone diseases
- M05B Drugs affecting bone structure and mineralization
- M05BA Bisphosphonates
- M05BB Bisphosphonates and calcium, sequential preparations
- M05BC Bone morphogenetic proteins
- M05BX Other drugs affecting bone structure and mineralization
- M05B Drugs affecting bone structure and mineralization
- M09 Other drugs for disorders of the musculo-skeletal system
- M09A Other drugs for disorders of the musculo-skeletal system
- M09AA Quinine and derivatives
- M09AB Enzymes
- M09AX Other drugs for disorders of the musculo-skeletal system
- M09A Other drugs for disorders of the musculo-skeletal system
- N01 Anesthetics
- N01A Anesthetics, general
- N01AA Ethers
- N01AB Halogenated hydrocarbons
- N01AF Barbiturates, plain
- N01AG Barbiturates in combination with other drugs
- N01AH Opioid anesthetics
- N01AX Other general anesthetics
- N01B Anesthetics, local
- N01BA Esters of aminobenzoic acid
- N01BB Amides
- N01BC Esters of benzoic acid
- N01BX Other local anesthetics
- N01A Anesthetics, general
- N02 Analgesics
- N02A Opioids
- N02AA Natural opium alkaloids
- N02AB Phenylpiperidine derivatives
- N02AC Diphenylpropylamine derivatives
- N02AD Benzomorphan derivatives
- N02AE Oripavine derivatives
- N02AF Morphinan derivatives
- N02AG Opioids in combination with antispasmodics
- N02AX Other opioids
- N02B Other analgesics and antipyretics
- N02BA Salicylic acid and derivatives
- N02BB Pyrazolones
- N02BE Anilides
- N02BG Other analgesics and antipyretics
- N02C Antimigraine preparations
- N02CA Ergot alkaloids
- N02CB Corticosteroid derivatives
- N02CC Selective serotonin (5HT1) agonists
- N02CX Other antimigraine preparations
- N02A Opioids
- N03 Antiepileptics
- N03A Antiepileptics
- N03AA Barbiturates and derivatives
- N03AB Hydantoin derivatives
- N03AC Oxazolidine derivatives
- N03AD Succinimide derivatives
- N03AE Benzodiazepine derivatives
- N03AF Carboxamide derivatives
- N03AG Fatty acid derivatives
- N03AX Other antiepileptics
- N03A Antiepileptics
- N04 Anti-parkinson drugs
- N04A Anticholinergic agents
- N04AA Tertiary amines
- N04AB Ethers chemically close to antihistamines
- N04AC Ethers of tropine or tropine derivatives
- N04B Dopaminergic agents
- N04BA Dopa and dopa derivatives
- N04BB Adamantane derivatives
- N04BC Dopamine agonists
- N04BD Monoamine oxidase B inhibitors
- N04BX Other dopaminergic agents
- N04A Anticholinergic agents
- N05 Psycholeptics
- N05A Antipsychotics
- N05AA Phenothiazines with aliphatic side-chain
- N05AB Phenothiazines with piperazine structure
- N05AC Phenothiazines with piperidine structure
- N05AD Butyrophenone derivatives
- N05AE Indole derivatives
- N05AF Thioxanthene derivatives
- N05AG Diphenylbutylpiperidine derivatives
- N05AH Diazepines, oxazepines and thiazepines
- N05AK Neuroleptics, in tardive dyskinesia
- N05AL Benzamides
- N05AN Lithium
- N05AX Other antipsychotics
- N05B Anxiolytics
- N05BA Benzodiazepine derivatives
- N05BB Diphenylmethane derivatives
- N05BC Carbamates
- N05BD Dibenzo-bicyclo-octadiene derivatives
- N05BE Azaspirodecanedione derivatives
- N05BX Other anxiolytics
- N05C Hypnotics and sedatives
- N05CA Barbiturates, plain
- N05CB Barbiturates, combinations
- N05CC Aldehydes and derivatives
- N05CD Benzodiazepine derivatives
- N05CE Piperidinedione derivatives
- N05CF Benzodiazepine related drugs
- N05CM Other hypnotics and sedatives
- N05CX Hypnotics and sedatives in combination, excluding barbiturates
- N05A Antipsychotics
- N06 Psychoanaleptics
- N06A Antidepressants
- N06AA Non-selective monoamine reuptake inhibitors
- N06AB Selective serotonin reuptake inhibitors
- N06AF Monoamine oxidase inhibitors, non-selective
- N06AG Monoamine oxidase A inhibitors
- N06AX Other antidepressants
- N06B Psychostimulants, agents used for ADHD and nootropics
- N06BA Centrally acting sympathomimetics
- N06BC Xanthine derivatives
- N06BX Other psychostimulants and nootropics
- N06C Psycholeptics and psychoanaleptics in combination
- N06CA Antidepressants in combination with psycholeptics
- N06CB Psychostimulants in combination with psycholeptics
- N06D Anti-dementia drugs
- N06DA Anticholinesterases
- N06DX Other anti-dementia drugs
- N06A Antidepressants
- N07 Other nervous system drugs
- N07A Parasympathomimetics
- N07AA Anticholinesterases
- N07AB Choline esters
- N07AX Other parasympathomimetics
- N07B Drugs used in addictive disorders
- N07BA Drugs used in nicotine dependence
- N07BB Drugs used in alcohol dependence
- N07BC Drugs used in opioid dependence
- N07C Antivertigo preparations
- N07CA Antivertigo preparations
- N07X Other nervous system drugs
- N07XA Gangliosides and ganglioside derivatives
- N07XX Other nervous system drugs
- N07A Parasympathomimetics
P Antiparasitic products, insecticides and repellents
- P01 Antiprotozoals
- P01A Agents against amoebiasis and other protozoal diseases
- P01AA Hydroxyquinoline derivatives
- P01AB Nitroimidazole derivatives
- P01AC Dichloroacetamide derivatives
- P01AR Arsenic compounds
- P01AX Other agents against amoebiasis and other protozoal diseases
- P01B Antimalarials
- P01BA Aminoquinolines
- P01BB Biguanides
- P01BC Methanolquinolines
- P01BD Diaminopyrimidines
- P01BE Artemisinin and derivatives
- P01BX Other antimalarials
- P01C Agents against leishmaniasis and trypanosomiasis
- P01CA Nitroimidazole derivatives
- P01CB Antimony compounds
- P01CC Nitrofuran derivatives
- P01CD Arsenic compounds
- P01CX Other agents against leishmaniasis and trypanosomiasis
- P01A Agents against amoebiasis and other protozoal diseases
- P02 Anthelmintics
- P02B Antitrematodals
- P02BA Quinoline derivatives and related substances
- P02BB Organophosphorous compounds
- P02BX Other antitrematodal agents
- P02C Antinematodal agents
- P02CA Benzimidazole derivatives
- P02CB Piperazine and derivatives
- P02CC Tetrahydropyrimidine derivatives
- P02CE Imidazothiazole derivatives
- P02CF Avermectines
- P02CX Other antinematodals
- P02D Anticestodals
- P02DA Salicylic acid derivatives
- P02DX Other anticestodals
- P02B Antitrematodals
- P03 Ectoparasiticides, including scabicides, insecticides and repellents
- P03A Ectoparasiticides, including scabicides
- P03AA Sulphur containing products
- P03AB Chlorine containing products
- P03AC Pyrethrines, including synthetic compounds
- P03AX Other ectoparasiticides, including scabicides
- P03B Insecticides and repellents
- P03BA Pyrethrines
- P03BX Other insecticides and repellents
- P03A Ectoparasiticides, including scabicides
- R01 Nasal preparations
- R01A Decongestants and other nasal preparations for topical use
- R01AA Sympathomimetics, plain
- R01AB Sympathomimetics, combinations excluding corticosteroids
- R01AC Antiallergic agents, excluding corticosteroids
- R01AD Corticosteroids
- R01AX Other nasal preparations
- R01B Nasal decongestants for systemic use
- R01BA Sympathomimetics
- R01A Decongestants and other nasal preparations for topical use
- R02 Throat preparations
- R02A Throat preparations
- R02AA Antiseptics
- R02AB Antibiotics
- R02AD Anesthetics, local
- R02A Throat preparations
- R03 Drugs for obstructive airway diseases
- R03A Adrenergics, inhalants
- R03AA Alpha- and beta-adrenoreceptor agonists
- R03AB Non-selective beta-adrenoreceptor agonists
- R03AC Selective beta-2-adrenoreceptor agonists
- R03AH Combinations of adrenergics
- R03AK Adrenergics and other drugs for obstructive airway diseases
- R03B Other drugs for obstructive airway diseases, inhalants
- R03BA Glucocorticoids
- R03BB Anticholinergics
- R03BC Antiallergic agents, excluding corticosteroids
- R03BX Other drugs for obstructive airway diseases, inhalants
- R03C Adrenergics for systemic use
- R03CA Alpha- and beta-adrenoreceptor agonists
- R03CB Non-selective beta-adrenoreceptor agonists
- R03CC Selective beta-2-adrenoreceptor agonists
- R03CK Adrenergics and other drugs for obstructive airway diseases
- R03D Other systemic drugs for obstructive airway diseases
- R03DA Xanthines
- R03DB Xanthines and adrenergics
- R03DC Leukotriene receptor antagonists
- R03DX Other systemic drugs for obstructive airway diseases
- R03A Adrenergics, inhalants
- R05 Cough and cold preparations
- R05C Expectorants, excluding combinations with cough suppressants
- R05CA Expectorants
- R05CB Mucolytics
- R05D Cough suppressants, excluding combinations with expectorants
- R05DA Opium alkaloids and derivatives
- R05DB Other cough suppressants
- R05F Cough suppressants and expectorants, combinations
- R05FA Opium derivatives and expectorants
- R05FB Other cough suppressants and expectorants
- R05X Other cold combination preparations
- R05C Expectorants, excluding combinations with cough suppressants
- R06 Antihistamines for systemic use
- R06A Antihistamines for systemic use
- R06AA Aminoalkyl ethers
- R06AB Substituted alkylamines
- R06AC Substituted ethylene diamines
- R06AD Phenothiazine derivatives
- R06AE Piperazine derivatives
- R06AK Combinations of antihistamines
- R06AX Other antihistamines for systemic use
- R06A Antihistamines for systemic use
- R07 Other respiratory system products
- R07A Other respiratory system products
- R07AA Lung surfactants
- R07AB Respiratory stimulants
- R07AX Other respiratory system products
- R07A Other respiratory system products
- S01 Ophthalmologicals
- S01A Anti-infectives
- S01AA Antibiotics
- S01AB Sulphonamides
- S01AD Antivirals
- S01AX Other anti-infectives
- S01B Anti-inflammatory agents
- S01BA Corticosteroids, plain
- S01BB Corticosteroids and mydriatics in combination
- S01BC Anti-inflammatory agents, non-steroids
- S01C Anti-inflammatory agents and anti-infectives in combination
- S01CA Corticosteroids and anti-infectives in combination
- S01CB Corticosteroids/anti-infectives/mydriatics in combination
- S01CC Anti-inflammatory agents, non-steroids and anti-infectives in combination
- S01E Antiglaucoma preparations and miotics
- S01EA Sympathomimetics in glaucoma therapy
- S01EB Parasympathomimetics
- S01EC Carbonic anhydrase inhibitors
- S01ED Beta blocking agents
- S01EE Prostaglandin analogues
- S01EX Other antiglaucoma preparations
- S01F Mydriatics and cycloplegics
- S01FA Anticholinergics
- S01FB Sympathomimetics excluding antiglaucoma preparations
- S01G Decongestants and antiallergics
- S01GA Sympathomimetics used as decongestants
- S01GX Other antiallergics
- S01H Local anesthetics
- S01HA Local anesthetics
- S01J Diagnostic agents
- S01JA Colouring agents
- S01JX Other ophthalmological diagnostic agents
- S01K Surgical aids
- S01KA Viscoelastic substances
- S01KX Other surgical aids
- S01X Other ophthalmologicals
- S01XA Other ophthalmologicals
- S01A Anti-infectives
- S02 Otologicals
- S02A Anti-infectives
- S02AA Anti-infectives
- S02B Corticosteroids
- S02BA Corticosteroids
- S02C Corticosteroids and anti-infectives in combination
- S02CA Corticosteroids and anti-infectives in combination
- S02D Other otologicals
- S02DA Analgesics and anesthetics
- S02DC Indifferent preparations
- S02A Anti-infectives
- S03 Ophthalmological and otological preparations
- S03A Anti-infectives
- S03AA Anti-infectives
- S03B Corticosteroids
- S03BA Corticosteroids
- S03C Corticosteroids and anti-infectives in combination
- S03CA Corticosteroids and anti-infectives in combination
- S03D Other ophthalmological and otological preparations
- S03A Anti-infectives
V Various
- V01 Allergens
- V01A Allergens
- V01AA Allergen extracts
- V01A Allergens
- V03 All other therapeutic products
- V03A All other therapeutic products
- V03AB Antidotes
- V03AC Iron chelating agents
- V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
- V03AF Detoxifying agents for antineoplastic treatment
- V03AG Drugs for treatment of hypercalcemia
- V03AH Drugs for treatment of hypoglycaemia
- V03AK Tissue adhesives
- V03AM Drugs for embolisation
- V03AN Medical gases
- V03AX Other therapeutic products
- V03AZ Nerve depressants
- V03A All other therapeutic products
- V04 Diagnostic agents
- V04B Urine tests
- V04C Other diagnostic agents
- V04CA Tests for diabetes
- V04CB Tests for fat absorption
- V04CC Tests for bile duct patency
- V04CD Tests for pituitary function
- V04CE Tests for liver functional capacity
- V04CF Tuberculosis diagnostics
- V04CG Tests for gastric secretion
- V04CH Tests for renal function
- V04CJ Tests for thyreoidea function
- V04CK Tests for pancreatic function
- V04CL Tests for allergic diseases
- V04CM Tests for fertility disturbances
- V04CX Other diagnostic agents
- V06 General nutrients
- V06A Diet formulations for treatment of obesity
- V06AA Low-energy diets
- V06B Protein supplements
- V06C Infant formulas
- V06CA Nutrients without phenylalanine
- V06D Other nutrients
- V06DA Carbohydrates/proteins/minerals/vitamins, combinations
- V06DB Fat/carbohydrates/proteins/minerals/vitamins, combinations
- V06DC Carbohydrates
- V06DD Amino acids, including combinations with polypeptides
- V06DE Amino acids/carbohydrates/minerals/vitamins, combinations
- V06DF Milk substitutes
- V06DX Other combinations of nutrients
- V06A Diet formulations for treatment of obesity
- V07 All other non-therapeutic products
- V07A All other non-therapeutic products
- V07AA Plasters
- V07AB Solvents and diluting agents, including irrigating solutions
- V07AC Blood transfusion, auxiliary products
- V07AD Blood tests, auxiliary products
- V07AN Incontinence equipment
- V07AR Sensitivity tests, discs and tablets
- V07AS Stoma equipment
- V07AT Cosmetics
- V07AV Technical disinfectants
- V07AX Washing agents etc.
- V07AY Other non-therapeutic auxiliary products
- V07AZ Chemicals and reagents for analysis
- V07A All other non-therapeutic products
- V08 Contrast media
- V08A X-ray contrast media, iodinated
- V08AA Water-soluble, nephrotropic, high osmolar X-ray contrast media
- V08AB Water-soluble, nephrotropic, low osmolar X-ray contrast media
- V08AC Water-soluble, hepatotropic X-ray contrast media
- V08AD Non-watersoluble X-ray contrast media
- V08B X-ray contrast media, non-iodinated
- V08BA Barium sulphate containing X-ray contrast media
- V08C Magnetic resonance imaging contrast media
- V08CA Paramagnetic contrast media
- V08CB Superparamagnetic contrast media
- V08CX Other magnetic resonance imaging contrast media
- V08D Ultrasound contrast media
- V08DA Ultrasound contrast media
- V09 Diagnostic radiopharmaceuticals
- V09A Central nervous system
- V09AA Technetium (99mTc) compounds
- V09AB Iodine (123I) compounds
- V09AX Other central nervous system diagnostic radiopharmaceuticals
- V09B Skeleton
- V09BA Technetium (99mTc) compounds
- V09C Renal system
- V09CA Technetium (99mTc) compounds
- V09CX Other renal system diagnostic radiopharmaceuticals
- V09D Hepatic and reticulo endothelial system
- V09DA Technetium (99mTc) compounds
- V09DB Technetium (99mTc) , particles and colloids
- V09DX Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals
- V09E Respiratory system
- V09EA Technetium (99mTc) inhalants
- V09EB Technetium (99mTc) particles for injection
- V09EX Other respiratory system diagnostic radiopharmaceuticals
- V09F Thyroid
- V09FX Various thyroid diagnostic radiopharmaceuticals
- V09G Cardiovascular system
- V09GA Technetium (99mTc) compounds
- V09GB Iodine (125I) compounds
- V09GX Other cardiovascular system diagnostic radiopharmaceuticals
- V09H Inflammation and infection detection
- V09HA Technetium (99mTc) compounds
- V09HB Indium (111In) compounds
- V09HX Other diagnostic radiopharmaceuticals for inflammation and infection detection
- V09I Tumour detection
- V09IA Technetium (99mTc) compounds
- V09IB Indium (111In) compounds
- V09IX Other diagnostic radiopharmaceuticals for tumour detection
- V09X Other diagnostic radiopharmaceuticals
- V09XA Iodine (131I) compounds
- V09XX Various diagnostic radiopharmaceuticals
- V09A Central nervous system
- V10 Therapeutic radiopharmaceuticals
- V10A Anti-inflammatory agents
- V10AA Yttrium (90Y) compounds
- V10AX Other anti-inflammatory therapeutic radiopharmaceuticals
- V10B Pain palliation (bone seeking agents)
- V10BX Various pain palliation radiopharmaceuticals
- V10X Other therapeutic radiopharmaceuticals
- V10XA Iodine (131I) compounds
- V10XX Various therapeutic radiopharmaceuticals
- V10A Anti-inflammatory agents
- V20 Surgical dressings